Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response.

Int J Colorectal Dis · 2016 · PMC4867152 · PMID 27075314

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

The reduction in Wexner score after 8 weeks of treatment when compared with baseline was highly significant for all NRL001 treatment arms ( p < 0.0001) as well as placebo.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.